𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II Trial of Imatinib in AIDS-Associated Kaposi's Sarcoma: AIDS Malignancy Consortium Protocol 042

✍ Scribed by Koon, H. B.; Krown, S. E.; Lee, J. Y.; Honda, K.; Rapisuwon, S.; Wang, Z.; Aboulafia, D.; Reid, E. G.; Rudek, M. A.; Dezube, B. J.; Noy, A.

Book ID
127026079
Publisher
American Society of Clinical Oncology
Year
2014
Tongue
English
Weight
195 KB
Volume
32
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase 1/2 trial of BMS-275291 in patient
Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma : A multicenter trial of the AIDS Malignancy Consortium
✍ Brett T. Brinker; Susan E. Krown; Jeannette Y. Lee; Ethel Cesarman; Amy Chadburn πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

## Abstract ## BACKGROUND. Matrix metalloproteinases (MMPs) are overexpressed in Kaposi sarcoma (KS). The safety and efficacy of a novel, orally bioavailable MMP inhibitor, BMS‐275291, was evaluated in patients with human immunodeficiency virus‐associated KS and the correlation between changes in